key: cord-0806791-8az9f4tp authors: Giraud-Gatineau, Audrey; Kaba, Lancei; Boschi, Céline; Devaux, Christian; Casalta, Jean-Paul; Gautret, Philippe; Chaudet, Hervé; Colson, Philippe; Raoult, Didier title: Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures: Common viral epidemics during SARS-CoV-2 pandemic, southern France date: 2022-04-16 journal: J Clin Virol DOI: 10.1016/j.jcv.2022.105163 sha: 4a883ffa0fce3e135e907c0b019071c2cb95033a doc_id: 806791 cord_uid: 8az9f4tp BACKGROUND: We systematically survey respiratory and gastrointestinal infections of viral origin in samples sent to our university hospital institute in Marseille, southern France. Here, we evaluated whether the measures implemented to fight COVID-19 had an effect on the dynamics of viral respiratory or gastrointestinal infections. METHODS: We analysed PCR performed and positive for the diagnoses of viral respiratory and gastrointestinal infections over five years (January 2017-February 2021). Data were collected from our epidemiological surveillance system (MIDaS). Dates and contents of French measures against SARS-CoV-2 were collected from: https://www.gouvernement.fr/info-coronavirus/les-actions-du-gouvernement. RESULTS: Over the 2017-2021 period, 990,364 analyses were carried out for respiratory infections not including SARS-CoV-2, 511,381 for SARS-CoV-2 and 27,719 for gastrointestinal infections. During winter 2020–2021, when the most restrictive lockdown measures were in place in France, a marked decrease of infections with influenza viruses (one case versus 1,839-1,850 cases during 2017-2020 cold seasons) and with the RSV (56 cases versus 988-1,196 cases during 2017-2020 cold seasons) was observed, demonstrating the relative effectiveness of these measures on their occurrence. SARS-CoV-2 incidence seemed far less affected. Rhinoviruses, parainfluenza 3 virus, and the NL63 coronavirus remained at comparable levels. Also, the norovirus winter season positivity rates decreased continuously and significantly over time from 9.3% in 2017–2018 to 2.0% in 2020–2021. CONCLUSION: The measures taken to control COVID-19 were effective against lower respiratory tract infections viruses and gastroenteritis agents, but not on the agents of the common winter cold and SARS-CoV-2. This suggests that more specific measures to prevent COVID-19 and upper respiratory tract infections need to be discovered to limit the spread of this epidemic. These measures had already been used in prevention campaigns for other viruses, particularly respiratory viruses such as influenza [10, 11] . More restrictive measures on movement were also taken, with the implementation of a number of lockdowns and curfews (Decree No. 2020-260; Decree No. 2020-1310) [12, 13] . Thus, in addition to the fight against COVID-19, these measures may also be effective at controlling other communicable respiratory and digestive diseases. At the Hospital University Institute Méditerranée Infection (IHU-MI), the work of the virology and microbiology laboratory is monitored by a collection and surveillance system known as MIDaS (for Mediterranée Infection Data Warehousing and Surveillance) [14, 15] . This system enables us to monitor respiratory and digestive virus infections on a weekly basis, and has included COVID-19 since its emergence in France [16] . The objective of this paper was to analyse the epidemiological curves of respiratory and gastrointestinal viruses since the emergence of SARS-CoV-2 and to evaluate if they changed under the measures implemented against COVID-19 in France by comparing them during cold seasons over the past five years. Since 2003, the work of our clinical microbiology laboratory has involved massive and unbiased monitoring of all clinical samples received for testing bacteria, viruses, parasites and fungi (16, 17) . This followed recommendations one of the authors (DR) [18] made to the French government in 2003 to set up surveillance systems of any abnormal events related to infectious diseases based on our laboratory data, including through syndromic surveillance. These are the only laboratories to diagnose infections for all public university hospitals (Assistance Publique -Hôpitaux de Marseille (AP-HM)) in Marseille, which has a total of 3,288 beds with nearly 125,000 admissions and one million consultations per year. Our laboratory conducts approximately eight million tests every year. Since 2013 when the IHU-MI was established, our surveillance tools have expanded further and have improved through our unique MIDaS (for Mediterranée Infection Data Warehousing and Surveillance) collection and surveillance system, which consists of five sub-systems [14] . We systematically collect all laboratory data (samples, tests, positive diagnoses) from the Nexlab laboratory management system. All microbiological analysis results (sample identification, requesting department, date, sampling, analysis, result, antibiotic susceptibility testing, antibiotic resistance phenotype, bacterial co-identifications) and patient information (anonymised patient identification, age, sex, home postal code, anonymised hospital stay identification, date of stay within a department, death) are then deposited in a dedicated data warehouse. All samples, tests and infectious agents are monitored on a weekly basis throughout the year. MIDaS automatically detects any aberrations in the statistical signal using the cumulative sum control chart (CUSUM) algorithm and triggers alarms [19] . These alarms are discussed during a weekly epidemiological staff meeting, which includes epidemiologists, biologists, infectiologists and pharmacists. Respiratory and gastrointestinal samples and infectious agents are some of the items surveyed. Generally speaking, respiratory and gastrointestinal viruses are diagnosed in our laboratory using commercial or in-house real-time Polymerase Chain Reaction (qPCR) tests and adopting a syndromic approach using multiplex tests or simplex tests. These include influenza A and B viruses, respiratory syncytial virus (RSV), rhinoviruses, enteroviruses, adenoviruses, metapneumovirus, endemic coronaviruses (OC43, NL63, E229 and HKU1), parainfluenza viruses 1 to 4 (HPIV1 to HPIV4) and SARS-CoV-2, over a period of time from RT-PCR procedures previously described [20] . To detect the other respiratory viruses, we used the FTD Respiratory pathogens 21 (Fast Track Diagnosis, Luxembourg), the Biofire FilmArray Respiratory panel 2 plus (BioMérieux, Marcy-l'Etoile, France), the Respiratory Multi-Well System r-gene (Argene, BioMérieux), or the GeneXpert Xpert Flu/RSV (Cepheid, Sunnyvale, CA) assays [21] . Data on diagnoses of influenza A and B viruses were also collected from a private clinical microbiology and virology laboratory through the PACASurvE (for the Provence Alpes-Côte d'Azur Surveillance Epidemiological System) network that extents our surveillance system to private medical biology laboratories located in the Marseille geographical area [22] . These diagnoses were reached by an immunochromatographic assay in 2017 and then switched to the GeneXpert Flu/RSV assay between 2018 and 2021. The gastrointestinal viruses diagnosed included adenoviruses, rotaviruses, sapoviruses, noroviruses and astroviruses. The tests were performed using the Fast Track Diagnosis (FTD) viral gastroenteritis pathogens assay. In order to better understand the evolution of respiratory and gastrointestinal virus [23] . Measures taken by the French government in the fight against the spread of SARS-CoV-2 and dates these measures were implemented were collected from the government website (https://www.gouvernement.fr/info-coronavirus/les-actions-du-gouvernement). Over a period of five years (January 2017 to February 2021), 990,364 analyses were performed for common respiratory viruses, with 37,915 positive results. Most of these cases were due to influenza viruses (influenza A virus, 6,544; influenza B viruses, 2,459) followed by rhinoviruses (7, Slight yearly variations were observed from 2017 to 2019 with regards to the respective prevalence of these viruses (Fig. 1 ). In 2017, the influenza A virus was the most frequently identified respiratory viral agent (12.1%), followed by rhinovirus (9.3%) and RSV (7.2%). In the same year, 1.7% of samples tested for influenza B virus were positive for this agent. In 2018, the rhinovirus was the most commonly diagnosed (12.6%), compared to 6.9% for RSV, 6.3% for influenza A virus and 5.2% for influenza B virus. 2019 was comparable to 2017 in terms of the ranking of respiratory viruses, although the proportions of respiratory viruses' diagnoses were higher in 2019. The intensity of the epidemic peak for each of these respiratory viruses therefore changed over the years, as did the date upon which they appeared ( Fig. 1 ). Since February 2020, 511,381 samples have been analysed for SARS-CoV-2 and 34,959 tested positive (6.8%). Of 420,120 samples tested for SARS-CoV-2 in 2020, 6.4% (N = 26,723) were positive while in 2021, out of 90,551 samples, 9.1% were positive. The government introduced several restrictive measures in an attempt to mitigate the spread of SARS-CoV-2 and to control the epidemic as effectively as possible. A first lockdown was imposed between 17 March 2020 and 11 May 2020, recommendations have been in place on wearing masks in enclosed spaces (particularly in the workplace) since 20 July 2020, a curfew was introduced between 8pm and 6am between 17 October 2020 and 28 October 2020, a second lockdown took place between 29 October 2020 and 15 December 2020, and a new curfew was introduced on 16 January 2021 from 6pm to 6am. In addition to these actions, individual preventive measures have also been recommended, including hand washing with soap or alcohol-based hand gel, a distance of 1.5 metres between individuals and the promotion of remote working. In 2020, the proportion of positive tests dramatically decreased to 7.7% for rhinovirus, 5.2% for influenza A, 4.5% for influenza B and 1.5% for RSV. This was also the case for the first two months of 2021, where no cases of influenza A or B were observed. In the first two months of 2021, the most frequently diagnosed virus was SARS-CoV-2 (9.1%), followed by rhinovirus (8.5%), parainfluenza virus (6.1%, mainly HPIV3: 5.7%) and other endemic coronaviruses (5.2%, mainly NL63: 3.2%). The same results were observed from a private clinical microbiology and virology laboratory through the PACASurvE network (Table 2) . In order to avoid the Simpson effect, which is the presence of second order interactions between all factors that inverse statistical relations when data are pooled [24] , samples analysed). As was previously observed for respiratory viruses, the intensity of the epidemic peak as well as the date of its onset varied over the years (Fig. 2) . In 2017, 2018 and 2020, adenovirus was the most frequently identified virus (5.0%, 7.6% and 4.1% respectively) while in 2019, rotavirus (8.6%) was the virus most commonly identified. In the first two months of 2021, of the 255 samples analysed, rotavirus was again the most frequently identified virus (N = 12, 4.7%) followed by norovirus (N = 10, 3.9%) and adenovirus (N = 10, 3.9%). The overall positivity rate of gastrointestinal infections decreased significantly over time during the winter seasons (Table 5) The impact of measures to control COVID-19 probably played a major role in these epidemiological changes [28] . These measures included both repeated recommendations on risk prevention measures such as hand washing with soap or alcohol-based hand gel, disinfecting surfaces, and social distancing, but also actions which were legally enforced, including wearing masks and the implementation of lockdown or curfews [9, 29] . Hand washing and disinfection was probably the main factor having an impact upon the usual respiratory and gastrointestinal viral infections [30] , and have been key elements of influenza prevention campaigns for several years [11] . It is not clear from the literature that lockdown measures and other social control measures have really had an impact on the spread of SARS-CoV-2 or on other respiratory infections [31] . For example, Sweden has issued very few social control measures while other countries such as France have implemented relatively strong measures without significantly differences in the number of cases or mortality [32] . The lack of effectiveness of these measures on the COVID-19 epidemic raises several questions. The first is the existence of infection outbreaks in animals which are distinct from outbreaks in humans. It has been demonstrated that the emergence of new variants could be promoted by the intensive captive breeding of certain animals such as mink, which are likely to contaminate humans by being potentially more contagious or more pathogenic for humans [34] [35] [36] . Furthermore, it seems likely that a certain number of treatments, including serotherapy with hyper-human sera and antivirals such as remdesivir, can promote the appearance of mutations [37] . Strong reductions in the incidence of some but not all respiratory viruses, and of viral agents of gastrointestinal infections have been also reported in several countries worldwide. This has been particularly noticed for influenza virus infections [28] . Tanislav influenza viruses and RSV, respectively, in children in Western Australian through winter 2020 [41] . In Singapore, influenza virus positivity rate decreased by 64% during weeks 5-9 of 2020 compared with the preceding years [42] . The present study has several limitations. We focused on the epidemiology of respiratory and gastrointestinal viruses only over the last four cold seasons in our institute. We analyzed here a limited number of seasons but notwithstanding these data further support the unpredictability of the epidemiology of these viruses. We observed considerable variations from season to season throughout the respiratory virus epidemic period regarding the predominant viruses, the time of emergence and duration of winter epidemics, the level of incidence reached at the epidemic peaks, and the time at which this peak occurred [15] . Also, we acknowledge that estimating hospitalization pattern in the typical pre-SARS-CoV-2 season may be the subject of large random variation. Here, we have not analyzed the impact of respiratory viruses on hospital admissions, but their impact on hospital mortality has been the subject of previous studies [15, 33] . Finally, the present work has been conducted in a single institution, and the results could therefore display local specificities. In conclusion, this study confirms that it is futile to try to make predictions about a disease for which the level of knowledge is limited [43] . The course of the epidemic over the past year was unpredictable and could not be integrated into any predictive models. Caution should be taken when using such models. Furthermore, this leads to the search for different modes of transmission of most respiratory diseases, as had already been mentioned in relation to SARS-CoV, where infections were retrospectively detected at a significant distance from the heart of the SARS-CoV outbreak, with no reasonable explanation [44] . Broad epidemiological surveillance of respiratory and gastrointestinal infections should be pursued in the future, as many changes occur during this pandemic among which public health policies and population behaviours including mask wearing or social distancing [31] . Also, in France, the issue of carriage and transmission by domestic pets has not been resolved and should be the subject of intense research to really understand the All data have been generated as part of the routine work at Assistance Publique-Hôpitaux de Marseille (Marseille university hospitals), and this study results from routine standard clinical management. The study was approved by the ethical committee of the University Hospital Institute Méditerranée Infection (N°: 2020-029 and 2022-015). Access to the patients' biological and registry data issued from the hospital information system was approved by the data protection committee of Assistance Publique-Hôpitaux de Marseille (APHM) and was recorded in the European General Data Protection Regulation registry under number RGPD/APHM 2019-73. contrast, adenovirus and rotavirus showed stable positivity rates between 2018-2019 (3.8% and 2.4% respectively) Characteristics of SARS-CoV-2 and COVID-19 An interactive web-based dashboard to track COVID-19 in real time Untangling introductions and persistence in COVID-19 resurgence in Europe Analysis of SARS-CoV-2 variants from 24,181 patients exemplifies the role of globalization and zoonosis in pandemics SARS-CoV-2 variants, spike mutations and immune escape The emergence, genomic diversity and global spread of SARS-CoV-2 Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination SARS-CoV-2 infectivity and severity of COVID-19 according to SARS-CoV-2 variants: Current evidence Surgical mask to prevent influenza transmission in households: a cluster randomized trial Prévenir la grippe saisonnière 2020-260 of 16 March 2020 introducing regulations on movement in the context of the fight against the spread of COVID-19 prescribing general measures required to combat the COVID-19 epidemic in the context of the health emergency situation Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection Epidemiological surveillance of respiratory viral infections at IHU Méditerranée Infection and its application to SARS-CoV-2 Real-time microbiology laboratory surveillance system to detect abnormal events and emerging infections EPIMIC: A Simple homemade computer program for real-time EPIdemiological surveillance and alert based on MICrobiological Data Rapport de mission Monitoring Count Time Series in R: Aberration Detection in Public Health Surveillance Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time Implementation and initial analysis of a laboratory-based weekly biosurveillance system A language and environment for statistical computing. R Foundation for Statistical Computing Simpson's paradox: A statistician's case study Bulletin épidémiologique grippe, semaine 7 How COVID-19 is changing the cold and flu season Decreased influenza activity during the COVID-19 pandemic -United States COVID-19 measures also suppress flu-for now prescribing general measures required to fight against the COVID-19 epidemic in regions where the health emergency has ended and those in which it has been prolonged COVID-19 restrictive measures are changing the flu season in Italy Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19 Covid-19 mortality: A matter of vulnerability among nations facing lmited margins of adaptation, Front Comparison of mortality associated with respiratory viral infections between Covid-19: natural or anthropic origin ? Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy Mink, SARS-CoV-2, and the human-animal interface A possible role of remdesivir and plasma therapy in the selective sweep and emergence of new SARS-CoV-2 variants Fewer non-COVID-19 respiratory tract infections and gastrointestinal infections during the COVID-19 pandemic Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic Disappearance of seasonal respiratory viruses in children under two years old during COVID-19 pandemic: A monocentric retrospective study in Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Decreased influenza incidence under COVID-19 control measures Predictive mathematical models of the COVID-19 pandemic: Underlying principles and value of projections Severe acute respiratory syndrome Winter of Omicron -The evolving COVID-19 pandemic The authors have no competing interests. Funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.